Indian pharma industry moving ahead from generics to MedTech

"From generics, we are now moving very fast into biosimilars. We are moving equally fast in MedTech. And you will...

EMA approves Biocon Biologics’ new monoclonal antibodies facility

According to a press release, this facility, designed to produce multiple drug substances, will now commence the...

Biocon Biologics gets U.S. FDA approval for Yesafili

Biocon Biologics announced that the U.S. Food and Drug Administration (US FDA) has approved the company's...

Glenmark is first to launch Biosimilar of Liraglutide in India

Mumbai (Maharashtra) [India], January 3: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global...

Intas Pharmaceuticals Ltd. Announces Licensing Agreement

Ahmedabad (Gujarat) [India], December 20: Intas Pharmaceuticals Ltd., a leading multinational pharmaceutical...

Flawless Pharma to invest USD 100 mn in buyout of Assets, Patents

New Delhi [India], August 2: Flawless Pharma Private Limited a research-based integrated pharmaceutical company...

European Medicine Agency accepts Intas' Marketing Authorization

Ahmedabad (Gujarat) [India], July 14: Intas Pharmaceuticals Ltd. announced that the European Medicine Agency (EMA)...

Aaquaries Global Industries Limited mulls investment

New Delhi [India], March 6 (ANI/SRV): Aaquaries Global Industries Limited, a research-based integrated...

Biocon Biologics completes acquisition of Viatris

Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE...

Biocon Biologics to acquire Viatris' Biosimilars Assets for...

Bengaluru (Karnataka) [India], March 1 (ANI/PR Newswire): Biocon Biologics Ltd, a subsidiary of Biocon Ltd (BSE...

India tops the chart for approved biosimilars and clinical...

Bengaluru (Karnataka) [India], September 24 (ANI/PRNewswire): With an overarching theme of 'Ideate and Innovate' and...

Enzene Biosciences Ltd. obtains a Marketing Authorization for...

Pune (Maharashtra) [India], August 27 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful...